# Wall Street’s Key Stock Analysts Research Reports, All Buys

Live Trading News is an independent financial media publication. Masthead: Live Trading News. Parent: Knightsbridge Group. Product cousin: KXCO (kxco.ai). Coverage: markets, policy, AI, quantum, blockchain, FX, biotech, ASEAN. New stories are signed ML-DSA-65 and anchored on Armature L1; articles published before the platform launch are not signed. Nothing on the site is investment advice.

Canonical HTML: https://www.livetradingnews.com/wall-streets-key-stock-analysts-research-reports-all-buys-34
Last modified: 2021-08-24

---

By Paul Ebeling · 2021-08-24
Tags: Shayne Heffernan on Investments, Stocks, stocks, Paul Ebeling
Signed: no (published before platform launch).
Nothing in this article is investment advice.

#[stocks](https://www.livetradingnews.com/stocks)[#bullish](https://www.livetradingnews.com/tag/bullish)[#buys](https://www.livetradingnews.com/tag/buys)[#analysts](https://www.livetradingnews.com/tag/analysts)[#research](https://www.livetradingnews.com/tag/research)[#WallStreet](https://www.livetradingnews.com/tag/wallstreet)

$ACVA $BILI $CADL $MXCT $RLYB 

Daily [HeffX](http://www.heffx.com/)-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new [trading ](https://exante.eu/p/8857/frommup/)and investing ideas for [HeffX](http://www.heffx.com/)-LTN readers. These reports cover [stocks](https://exante.eu/p/8857/frommup/) to [buy](https://clicks.pipaffiliates.com/c?c=229081&l=en&p=0) if you can manage the risk.

[These are all Buys if you can manage the risk.](https://www.livetradingnews.com/if-you-can-manage-the-risk-the-coronavirus-has-presented-opportunity-in-this-market-170367.html#.XnnNuogzYpo)

Below are our Buys for Tuesday, 24 August, as follows:

ACV Auctions Inc. ([NASDAQ:ACVA](NASDAQ:ACVA)): Citigroup upgraded the stock to Buy from Neutral but dropped the target price to 23 from 29. The consensus target is 36.

Bilbili Inc. ([NASDAQ:BILI](NASDAQ:BILI)): Goldman reiterated a Buy rating and cut its price target to 105 from $122. Shares traded in a 52-wk range of 40.40 - 157.66.

Candel Therapeutics Inc. ([NASDAQ:CADL](NASDAQ:CADL)): UBS initiated coverage with a Buy rating and a 9 price target. Credit Suisse started it with an Outperform rating and a 15 price target, and Jefferies started it with a Buy rating and a 22 price target. 

MaxCyte Inc. ([NASDAQ:MXCT](NASDAQ:MXCT)): Stifel initiated coverage with a Buy rating and an 18 price target. BTIG started it with a Buy rating and a 22 price target. The stock trades in a 52-wk range of 13.77 - 17.44.

Rallybio Corp. ([NASDAQ:RLYB](NASDAQ:RLYB)): Jefferies started coverage with a Buy rating and a 20 price target. Since the IPO, the shares have traded between 11.86 - 25.78

Have a prosperous day, Keep the Faith!

---

This Markdown mirrors https://www.livetradingnews.com/wall-streets-key-stock-analysts-research-reports-all-buys-34. The HTML page is canonical.
Site index for AI clients: https://www.livetradingnews.com/llms.txt